Altnagelvin Hospital

Trial FLAIR
Cancer Type Haematological Cancers and Leukaemia
Hospital(s) Altnagelvin Hospital, Belfast City Hospital, and Craigavon Hospital
Information

Front-Line therapy in CLL: Assessment of Ibrutinib + Rituximab

Click Here to view CancerHelpUK trial summary
Trial KEYNOTE-B49
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital
Information

A Randomised, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for the Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Metastatic Breast Cancer

Trial Lantern Pharma
Cancer Type Prostate Cancer
Hospital(s) Altnagelvin Hospital
Information

Biomarker analysis using fresh biopsy tissue

Trial MOSAICC
Cancer Type Haematological Cancers and Other Haematological
Hospital(s) Altnagelvin Hospital, Antrim Hospital, Belfast City Hospital, Craigavon Hospital, and Ulster Hospital
Information

MyeloprOliferative NeoplasmS An In-Depth Case-Control Study: A Case-Control Study Of Patients With Myeloproliferative Neoplasms And Non-Blood Relative/Friend Controls

Trial NERELYFE Study
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital
Information

Multicenter, multi-country, prospective, observational, post authorisation safety study to describe the incidence of discontinuation due to diarrhoea within the first 3 months of treatment with neratinib, in adult breast cancer patients treated in extended adjuvant in a real world setting: the NERLYFE study. Ancillary study: A Nerlyfe ancillary study to describe recurrence in breast cancer patients treated with neratinib in a real-world setting

Trial SMALL Trial
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital, Belfast City Hospital, and Craigavon Hospital
Information

A Phase III, randomised, multi-centre trial addressing overtreatment of small screen-detected breast cancer by comparing standard surgery versus minimally invasive vacuum-assisted excision

Trial TROPION - 03
Cancer Type Breast Cancer
Hospital(s) Altnagelvin Hospital
Information

A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator’s Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Who Have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy (TROPION-Breast03)

Trial UKGPC
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Altnagelvin Hospital, Antrim Hospital, and Ulster Hospital
Information

UK Genetics Prostate Cancer Study

Click Here to view CancerHelpUK trial summary